Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MABEL trial of modified-release morphine for chronic breathlessness
ISRCTN87329095Phase 3Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Mar 2021
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial comparing Modified-release morphine + docusate with Placebo morphine + placebo docusate (2 arms). Primary endpoint: Worst breathlessness over the previous 24 hours at day 28. Started Mar 2021; status: completed.
02
Drugs
morphinedocusate sodium
Beyond the preview
Go deeper on ISRCTN87329095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN87329095.